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Cancer is a leading cause of death worldwide, being breast cancer amongst the most common forms of 
the disease. Advances in health-related practices have anticipated the detection of breast cancer and 
allowed establishing appropriate follow-up procedures. Monitoring circulating biomarkers as CA15-3 is 
amongst the several tools used to this end. Thus, there is great interest in developing new biosensors for 
CA15-3 that are suitable for a point-of-care (POC) use. 
This work describes the application of an eco-friendly substrate to assembly a new sensor for CA15-3 
detection in POC. It consists in the development of an artificial antibody based on molecularly imprinted 
polymer (MIP) technology and electropolymerization of o-phenylenediamine (o-PD). The polymer was 
tailored on a glass microscope slide hand-coated with a commercial conductive carbon inks based on 
screen-printed electrodes technique (C-glass SPEs). Afterwards, the surface was modified with platinum 
nanoparticles (Pt NPs), followed by a bottom-up assembly of the artificial antibody for CA15-3 detection. 
The analytical performance of the resulting devices was performed through square wave voltammetry 
(SWV) and electrochemical impedance spectroscopy (EIS), showing sensitive readings for CA15-3 
concentrations ranging between 1.0 mU/mL and 100.0 U/mL in phosphate buffer (PB) pH7.50, with limit of 
detection (LOD) below 1.4 mU/mL. Chemical modifications of the surface were characterized using a 
confocal Raman-AFM spectroscopy and Scanning Electronic Microscopy (SEM). In general, the CA15-3 
artificial antibody was successfully applied in spiked fetal bovine serum (FBS) samples, demonstrating 
linear responses below to the normal physiological levels (30.0 U/mL). Therefore, the developed sensing 
material may be a simple, selective and a promising tool to monitor this cancer biomarker in a clinical 
context. 
 
Keywords: Cancer, CA15-3 biomarker, Protein surface imprinting, Glass substrate, Homemade screen-
printed electrodes (C-glass SPEs). 
 
 
 
 
 
 
Acknowledgements: We thank funding to the European Research Council, through the Starting Grant 3P’s 
(GA311086, given to MGFS) and to Norte 2020 - Programa Operacional Regional do Norte, through the project 
CANCER (NORTE-01-0145-FEDER-000029). The authors also thank due to CICECO-Aveiro Institute of Materials, 
POCI-01-0145-FEDER-007679 (FCT Ref. UID/CTM/50011/2013). 
  
